Will KHC record any single goodwill or intangible asset impairment charge above $2B during 2026?

Two competing forces: (1) The 8-year base rate of impairments > $2B is 4 of 8 years = 50%, suggesting elevated probability. (2) The 2025 charge of $9.3B was a major reset that pulled forward expected future write-downs — typically post-large-impairment years see a 'cooling off' period. Coffee/Maxwell House and Oscar Mayer are the most at-risk reporting units; if their FY26 performance disappoints, a $2-4B charge is plausible. The Q3 2026 testing cycle (Oct/Nov 2026) is the most likely timing window. Discount rate sensitivity: every 50 bps Treasury yield move can trigger reporting unit fair value test failures. Net of base rate (50%) plus 2025-reset effect (-15%) plus Q3 trigger window timing in scope (+0%) = 32%. Below coin-flip but materially above tail-event territory.

Slightly less bearish. Post-$9.3B-impairment, the remaining $59.7B carrying value already reflects reduced expectations. For another $2B+ impairment in FY26 to occur, a NEW negative shock would need to emerge — discount rate spike, NA volume capitulating to -7pp, coffee or Oscar Mayer specific brand collapse. Each individually is 10-20% probability; combined OR probability ~30%. The Q3 2026 testing cycle is the natural trigger window. Cahillane has incentive to defer impairment — first-year CEOs typically resist 'kitchen sink' charges that would brand them as underperformers. Probability 28%.

Bear-leaning. The 8-year base rate of 50% is the natural anchor. The 2025 charge does NOT preclude a 2026 charge — KHC has had consecutive impairment years (2018 $15.4B then 2019 $1.2B then 2020 $2.9B). The pattern of impairments in 2018-2020 suggests once accounting unmoors from operating reality, multiple reset years can cluster. Carrying value at $59.7B remains 75% of total assets — the structural over-valuation question is not fully resolved. NA volume continuing at -5pp through H1 2026 would force Q3 2026 testing to fail at the Coffee/Oscar Mayer reporting unit. If Adj OI prints below low end of guide, a 'big bath' in connection with the rating action becomes attractive timing. Combining 50% base rate with KHC-specific factors lands at 40%.

The base rate (50%) suggests above coin-flip but we should adjust for: (a) 2025 reset effect (-15%), (b) Cahillane new-CEO defer incentive (-5%), (c) NA volume pressure that could force testing failures (+10%). Net: 40%. Then I'd discount for the $2B threshold being meaningful (smaller charges <$2B don't count) which trims another 10%. Land at 30%.

The pattern is clear: 6 discrete impairment events in 8 years totaling $33B+. Once the operating trajectory deteriorates and reporting unit fair values fall, impairments cascade. KHC has not yet stabilized operating performance. Q3 2026 testing cycle is the natural trigger. Probability 32%.

Lower probability. The 2025 charge was a major reset; consecutive-year large impairments are less common than year-after-year decline. Cahillane has strong incentive to keep impairments small or push them into 2027. 25%.

8-year base rate ~50% for impairments >$2B. 2025 reset effect lowers near-term probability. Cahillane defer incentive. NA volume pressure offsets. Net 30%.

Below coin flip. Post-$9.3B reset, additional $2B charge requires new shock. Q3 2026 testing window is natural trigger. 28%.

Pattern of 6 impairments in 8 years suggests continuation. NA volume + leverage pressure + carrying value still high. 32%.